Skip to main content

Find Clinical Trials

Home
Conditions
Neurodegenerative Diseases

Clinical trial condition

Neurodegenerative Diseases

Explore clinical trials studying Neurodegenerative Diseases. Study availability and eligibility vary by location and protocol.

8,970 public trials 1,744 recruiting studies

Refine in advanced search Browse all conditions

Neurodegenerative Diseases trial results

Completed

Integrated Multidisciplinary Care for Parkinson's Disease: a Controlled Trial

NCT00518791

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations: Ziekenhuis Groep Twente, Twenteborg Ziekenhuis Almelo, Netherlands

Ziekenhuis Rijnstate Arnhem, Netherlands

Wilhelmina Ziekenhuis Assen Assen, Netherlands

Ziekenhuis Groep Twente, Streekziekenhuis Midden-Twente Hengelo, Netherlands

View Trial Details

Completed

A Safety and Tolerability Study of ABT-126 in Elderly

NCT00867399

Conditions: Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
Locations: Site Reference ID/Investigator# 17283 Orlando, Florida, United States

View Trial Details

Completed

A Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Anti-Abeta (MABT5102A) in Patients With Alzheimer's Disease

NCT00736775

Conditions: Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
Locations: Not specified

View Trial Details

Completed

Safety/Tolerability, Immunological and Clinical Activity of a Boost Immunization With AFFITOPE AD02

NCT01093664

Conditions: Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
Locations: Ordination Schmitz Vienna, State of Vienna, Austria

View Trial Details

Completed

Tolerability and Safety of Subcutaneous Administration of Affitope AD01 in Mild to Moderate Alzheimer's Disease

NCT00495417

Conditions: Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
Locations: Department of Clinical Pharmacology, Medical University of Vienna Vienna, Austria

View Trial Details

Completed

Tolerability and Safety of Subcutaneous Administration of AFFITOPE AD02 in Mild to Moderate Alzheimer's Disease

NCT00633841

Conditions: Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
Locations: Ordination Univ. Doz. Dr. Margot Schmitz Vienna, Austria

View Trial Details

Completed

A Survey Study to See if Patients Diagnosed With Parkinson's Disease Have Higher Incidence of Melanoma

NCT00203008

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +20 more
Locations: Not specified

View Trial Details

Completed

Single-Ascending-Dose Safety/Tolerability of NP001 in Amyotrophic Lateral Sclerosis (ALS)

NCT01091142

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: California Pacific Medical Center San Francisco, California, United States

University of Kansas Medical Center - Landon Center on Aging Kansas City, Kansas, United States

Department of Neurology; University of Kentucky Medical Center Lexington, Kentucky, United States

View Trial Details

Completed

Safety, Tolerability and Pharmacokinetic Profile of Levodopa Administered With Continuous Administration of ND0611

NCT01103011

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations: Hadassah Medical Center Jerusalem, Israel

View Trial Details

Completed

Study of the Effects of Dopaminergic Medications on Dopamine Transporter Imaging in Parkinson's Disease

NCT00096720

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +10 more
Locations: Pacific Neuroscience Medical Group Oxnard, California, United States

Colorado Neurology, PC Englewood, Colorado, United States

Institute for Neurodegenerative Disorders New Haven, Connecticut, United States

University of Florida Movement Disorders Center Gainesville, Florida, United States

View all 13 locations

View Trial Details